** Shares of medical products distributor Medline MDLN.O fall 4.9% TO $47.55 premarket
** Co posted Q4 net income of $180 million vs $289 million a year earlier, missing analysts' average estimate of $337.28 million according to data compiled by LSEG
** MDLN says the 37.7% drop in net income year-over-year was due to an increase in costs of goods sold due to tariffs and higher operating costs, which includes investments in headcount and IPO-related expenses
** MDLN reports Q4 revenue of $7.79 billion, beating analysts' average estimate of $7.55 billion
** MDLN expects annual adjusted EBITDA in the range of $3.5 billion to $3.6 billion, vs estimates of $3.53 billion
** Medline's market debut was the largest public offering in the world last year
** MDLN up 19% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))